2,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → HCID 178458760, 화합물
반응식
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12](=[O:15])[CH2:13][CH3:14])=[C:5]2[NH:16][C@H:17]1[CH2:22][CH2:21][C@H:20]([N:23]([CH3:25])[CH3:24])[CH2:19][CH2:18]1.[Cl:26][C:27]1[CH:32]=[C:31](B2OC(C)(C)C(C)(C)O2)[CH:30]=[C:29]([Cl:42])[C:28]=1[OH:43]>>[Cl:42][C:29]1[CH:30]=[C:31]([C:2]2[CH:3]=[C:4]3[C:9](=[CH:10][CH:11]=2)[N:8]=[CH:7][C:6]([C:12](=[O:15])[CH2:13][CH3:14])=[C:5]3[NH:16][C@H:17]2[CH2:22][CH2:21][C@H:20]([N:23]([CH3:25])[CH3:24])[CH2:19][CH2:18]2)[CH:32]=[C:27]([Cl:26])[C:28]=1[OH:43]참가 물질
3
실험 절차
Following general procedure M, 1-(6-bromo-4-((trans-4-(dimethylamino)cyclohexyl)amino)quinolin-3-yl)propan-1-one (125 mg, 0.31 mmol) was reacted with 2,6-dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (98 mg, 0.34 mmol) to afford the desired product (74 mg, 49%) as a yellow solid. 1H NMR (500 MHz, DMSO d6) δ 10.58 (d, J=7.9 Hz, 1H), 8.96 (s, 1H), 8.30 (d, J=2.1 Hz, 1H), 8.03 (dd, J=8.7, 1.9 Hz, 1H), 7.84 (d, J=8.7 Hz, 1H), 7.771 (s, 2H), 4.19-4.15 (br s, 1H), 3.13 (q, J=7.2 Hz, 2H), 2.56-2.51 (m, 1H), 2.32 (s, 6H), 2.26-2.22 (m, 2H), 1.96-1.89 (m, 2H), 1.56-1.47 (m, 4H), 1.14 (t, J=7.2 Hz, 3H). APCI MS m/z 486 [C26H29Cl2N3O2+H]+; HPLC>99% (AUC), tR=8.28 min.